Research Information

Jim Boulter Publications
[Back]

Selected Publications(Newest Update Publication from PubMed)

Elgoyhen, A.B., Johnson, D.S., Boulter, J., Vetter, D.E., and Heinemann, S. (1994) Alpha 9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79: 705-715.

Lindsell, C.E., Shawber, C.J., Boulter, J. and Weinmaster, G.A. (1994) Jagged: A mammalian ligand that activates Notch. Cell 80: 909-917.

Lindsell, C.E., Boulter, J., di Sibio, G., and Weinmaster, G. (1996) Expression of Jagged, Delta1, Notch1, Notch2, and Notch3 identified ligand-receptor pairs that may function in vertebrate neural development. Molecular & Cellular Neuroscience 8:14-27.

Shawber, C.J., Boulter, J., Lindsell, C.E., and Weinmaster, G. (1996) Jagged2: A Serrate-like gene expressed during rat embryogenesis. Developmental Biology 180: 370-376.

Vetter, D. E., Liberman, M. C., Mann, J. Barhanin, J., Boulter, J., Brown, M. C., Saffiote-Kolman, J., Heinemann, S. F., and Elgoyhen, A. B. (1999) Role of a9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation. Neuron 23: 93-103.

Walker, L., Lynch, M. Silverman, S., Fraser, J. Boulter, J., Weinmaster, G., and Gasson, J. C. (1999) The Notch/Jagged pathway inhibits proliferation of human hematopoietic progenitors in vitro. Stem Cells 17: 162-171.

Kong, H., Boulter, J., Weber, J., Lai, C., and Chao, M. (2001) An evolutionarily conserved transmembrane protein that is a novel downstream target of neurotrophin and ephrin receptors. J. Neuroscience 21: 176-185.

Elgoyhen, A. B., Katz, E., Vetter, D. E., Rothlin, C. V., Heinemann, S., and Boulter, J. (2001) Alpha 10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. PNAS 98: 3501-3506.

Labarca, C., Schwarz, J., Deshpande, P., Schwarz, S., Nowak, M. W., Fonck, C., Nashimi, R., Kofuji, P., Dang, H., Shi, W., Fidan, M., Khakh, B. S., Chen, Z., Bowers, B. J., Boulter, J., Wehner, J. M., and Lester, H. A.(2001) Point mutant mice with hypersensitive a4 nicotinic receptors show dopaminergic deficits and increased anxiety. PNAS 98: 2786-2791.

Safa, P., Boulter, J., and Hales T. G. (2001) Functional properties of Ca_v1.3 (a1D) L-type Ca²⁺ channel splice variants expressed by rat brain and neuroendocrine GH₃ cells. J. Biol. Chem. 276: 38727-38737.

Haritunians, T., Boulter, J., Hicks, C., Buhrman, J., DiSibio, G., Shawber, C., Weinmaster, G., Nofziger, D., and Schanen, N. C. (2002). CADASIL Notch 3 mutant proteins localize to the cell surface and bind ligand. J. Circulation Research 90: 506-508.

Lioudyno, M. I., Verbitsky, M., Glowatzki, E., Holt, J. C., Boulter, J., Zadina, J. E., Elgoyhen, A. B., and Guth, P.S. (2002) The a9a10-containing nicotinic acetylcholine receptor is directly modulated by opioid peptides, endomorphin-1 and dynorphin B, proposed efferent co-transmitters in the inner ear. Molecular and Cellular Neuroscience (submitted).

Cui, C., Booker, T.K., Allen, R. Grady, S.R., Whiteaker, P., Tritto, T., Marks, M. J., Allen, W. R., McIntosh, J.M., Boulter, J., Collins, A., and Heinemann, S. (2002) b3 nicotinic receptors and dopaminergic transmission: Implications for Parkinson's. Science (submitted).